Andreessen Horowitz raised over $15 billion for new funds, marking a significant boost in U.S. venture capital amid a recent slowdown in fundraising, with the firm emphasizing the importance of pro-tech policies for America's global leadership.
True Ventures co-founder Jon Callaghan predicts that smartphones will become obsolete within five to ten years, as new, more natural interfaces for human-computer interaction are developed, based on the firm's investments in innovative technologies like wearables and smart home devices.
China has launched three venture capital funds, each with over 50 billion yuan, to invest in early-stage startups focused on hard technologies such as semiconductors, quantum tech, biomedicine, and aerospace, with a total emphasis on strategic technological development.
China has launched three venture capital funds, each with over 50 billion yuan ($7.14 billion), to invest in early-stage startups focused on hard technologies like integrated circuits, quantum tech, biomedicine, and aerospace, with no single investment exceeding 50 million yuan.
A group of former SpaceX employees, dubbed the SpaceX Mafia, have founded startups that have raised over $3 billion in venture funding, backed by top firms like Andreessen Horowitz and Founders Fund, shaping a new legacy similar to Elon Musk's PayPal Mafia.
Biotech venture capitalist Bruce Booth predicts a significant increase in IPOs for drug companies in 2026, following two years of low activity, signaling a potential sector recovery.
Dragoneer raised $4.3 billion for its seventh VC fund, surpassing expectations in a slow fundraising year, bringing its total assets under management to over $30 billion, with notable investments including OpenAI, Airbnb, and Uber.
Pfizer's $10 billion acquisition of Metsera, a company developing experimental weight loss drugs, highlights significant activity in biotech mergers and investments, with venture funds like Population Health Partners and ARCH Venture Partners poised to profit greatly. The deal underscores both opportunities and cautionary lessons in biotech M&A and investment strategies.
Goldman Sachs is acquiring Industry Ventures for up to $965 million to strengthen its alternatives platform amid a shift towards non-traditional venture exits like secondary transactions and buyouts, reflecting changing dynamics in the venture capital ecosystem.
Goldman Sachs is acquiring Industry Ventures, a $7 billion venture capital firm, for $665 million in cash and equity, with potential additional payments based on performance, aiming to enhance its venture investments and expand access to fast-growing sectors.
Nvidia has dramatically increased its investments in AI startups in 2025, participating in over 50 deals including major funding rounds for companies like OpenAI, xAI, Mistral AI, and Reflection AI, reflecting its strategic focus on expanding the AI ecosystem beyond its core GPU business.
A venture capital fund called Deep Future is investing in out-of-the-box, long-term technological ideas, including innovative nuclear reactors, e-waste recycling methods, and theoretical concepts like warp drives, aiming to fund projects that may take decades to realize but could revolutionize various industries.
AI is dominating startup investment in 2025, with over half of all VC money going into AI companies, primarily benefiting marquee firms like Anthropic, while overall startup funding has significantly decreased, creating a divide between AI and non-AI startups.
Jim Breyer, a billionaire venture capitalist known for early Facebook investments, has achieved another major success with Circle Internet Group and its stablecoin USDC, significantly boosting his fortune. He has a diverse portfolio, a strong focus on innovative tech and healthcare, and is actively involving his family in his investments. Despite personal tragedy, he remains committed to his vision of supporting founders and exploring new technological frontiers.
Venture capitalists are betting on AI transforming labor-intensive service industries by automating tasks to improve margins, but early signs suggest the complexity and unintended consequences of AI implementation, such as increased workslop and organizational strain, may challenge these optimistic projections.